Zdrowie i gospodarka · 22/02/2021

FDA Requests Public Comment on Proposed Collection of Information for Blood and Blood Components Regulation

The Food and Drug Administration is seeking public input on proposed regulations for blood and blood components, including current good manufacturing practices and requirements for donation testing and notification, as part of its efforts to modernize its oversight of the blood supply.